Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A128 or 6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).

Item

http://www.wikidata.org/entity/Q37567702

Q37567702

about

Relationship between UGT1A1*27 and UGT1A1*7 polymorphisms and irinotecan-related toxicities in patients with lung cancer.

P2860

Q47604049-FDF23D8B-22C7-4CE9-AE08-366D3D86E6C0

P2860

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A128 or 6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).

Item

http://www.wikidata.org/entity/Q37567702

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Phase I study of irinotecan fo ...... Group in Kyushu (LOGIK1004A).

@en

Phase I study of irinotecan fo ...... Lung Oncology Group in Kyushu

@nl

type

Item

label

Phase I study of irinotecan fo ...... Group in Kyushu (LOGIK1004A).

@en

Phase I study of irinotecan fo ...... Lung Oncology Group in Kyushu

@nl

prefLabel

Phase I study of irinotecan fo ...... Group in Kyushu (LOGIK1004A).

@en

Phase I study of irinotecan fo ...... Lung Oncology Group in Kyushu

@nl

P1476

Phase I study of irinotecan fo ...... Group in Kyushu (LOGIK1004A).

@en

P2093

Hiroshi Semba

http://www.w3.org/2001/XMLSchema#string

Isamu Okamoto

http://www.w3.org/2001/XMLSchema#string

Kenji Sugio

http://www.w3.org/2001/XMLSchema#string

Kohji Hashiguchi

http://www.w3.org/2001/XMLSchema#string

Koichi Takayama

http://www.w3.org/2001/XMLSchema#string

Midori Shimada

http://www.w3.org/2001/XMLSchema#string

Minoru Fukuda

http://www.w3.org/2001/XMLSchema#string

Noriyuki Ebi

http://www.w3.org/2001/XMLSchema#string

Seiji Nagashima

http://www.w3.org/2001/XMLSchema#string

Taishi Harada

http://www.w3.org/2001/XMLSchema#string

P2860

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

Genetic variants in the UDP-glucuronosyltransferase 1A1 gene predict the risk of severe neutropenia of irinotecan

Clinical significance of UDP-glucuronosyltransferase 1A1*6 for toxicities of combination chemotherapy with irinotecan and cisplatin in gynecologic cancers: a prospective multi-institutional study.

Polymorphisms of UDP-glucuronosyltransferase gene and irinotecan toxicity: a pharmacogenetic analysis.

Pharmacogenomics: road to anticancer therapeutics nirvana?

Systemic therapy for colorectal cancer.

Pharmacogenetics and irinotecan therapy.

Prospective study of the UGT1A1*27 gene polymorphism during irinotecan therapy in patients with lung cancer: Results of Lung Oncology Group in Kyusyu (LOGIK1004B).

Ethnic differences in the metabolism, toxicology and efficacy of three anticancer drugs.

UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma.

P304

40-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1759-7714.12407

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27883280

http://www.w3.org/2001/XMLSchema#string

P932

5217920

http://www.w3.org/2001/XMLSchema#string

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).

about

P2860

P2860

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A1*28 or *6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A128 or 6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).

Phase I study of irinotecan for previously treated lung cancer patients with the UGT1A128 or 6 polymorphism: Results of the Lung Oncology Group in Kyushu (LOGIK1004A).